Virtue Diagnostics closes USD100m Series B funding led by Sequoia China and Morningside Ventures
IVD company Virtue Diagnostics has closed a USD100 million Series B funding round jointly led by Sequoia China and Morningside Ventures. ORIZA Holdings also participated in the round alongside existing investors Lilly Asia Ventures and PerkinElmer Ventures. HAOYUE Capital acted as the exclusive financial advisor. Virtue Diagnostics is a global,